Robbins LLP logo white Background.png
Kenvue Inc. Shareholders: Robbins LLP Reminds Shareholders that the Lead Plaintiff Deadline is Quickly Approaching and Encourages Shareholders to Reach out for Information
November 21, 2023 19:06 ET | Robbins LLP
Kenvue Inc. (KVUE) Made False and Misleading Statements in its Registration Statement in Support of its IPO
Robbins LLP logo white Background.png
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against James River Group Holdings, Ltd. (JRVR)
November 21, 2023 18:29 ET | Robbins LLP
James River Group Holdings, Ltd. (JRVR) Lacked Effective Internal Control Over Financial Reporting
Robbins LLP logo white Background.png
Acelyrin, Inc. (SLRN) Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against Acelyrin, Inc.
November 21, 2023 18:20 ET | Robbins LLP
Acelyrin, Inc. (SLRN) Misled Investors Regarding its Lead Product Candidate
Robbins LLP logo white Background.png
SCYX STOCK NEWS: Investors with Significant Losses in Scynexis, Inc. Should Contact Robbins LLP for Information About the Scynexis, Inc. Class Action
November 21, 2023 17:05 ET | Robbins LLP
Scynexis, Inc. (SCYX) Misled Investors Regarding its Quality Control Measures
Robbins LLP logo white Background.png
OTLK STOCK NEWS: Investors with Significant Losses in Outlook Therapeutics, Inc. Should Contact Robbins LLP for Information About the Outlook Therapeutics, Inc. Class Action
November 21, 2023 16:52 ET | Robbins LLP
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
Robbins LLP logo white Background.png
Barclays PLC Class Action Reminder: Contact Robbins LLP for Information About the BCS Class Action
November 21, 2023 16:45 ET | Robbins LLP
Barclays (BCS) Misled Investors About the Relationship Between its CEO and Jeffrey Epstein
Robbins LLP logo white Background.png
Brainstorm Cell Therapeutics Inc. Class Action Reminder: Contact Robbins LLP for Information About the BCLI Class Action
November 21, 2023 16:39 ET | Robbins LLP
Brainstorm Cell Therapeutics Inc. (BCLI) Misled Investors About the Viability and Efficacy of its drug NurOwn
Robbins LLP logo white Background.png
HLLY STOCK NEWS: Investors with Significant Losses in Holley Inc. (f/k/a Empower Ltd.) Should Contact Robbins LLP for Information About the Holley Inc. Class Action
November 21, 2023 16:38 ET | Robbins LLP
Holley Inc. (HLLY) f/k/a Empower Ltd. (EMPW) Misled Investors Regarding its Ability to Integrate Acquisitions and Achieve Cost Synergies